May 2017 - FRMC

Issue 5
May 2017


By Paul Nicolaus

Clinical trials could represent a unique opportunity for significant cost savings while getting patients access to cutting-edge treatments. | Read More

 Eileen Koutnik-Fotopoulos

Challenges addressing pain are coming to a head at a time when the prevalence of comorbid neuropathic pain is on the rise. | Read More

By Jill Sederstrom

Industry experts argue that too much emphasis is put on the list prices of certain high-ticket drugs, when most patients are shielded by pharmacy benefits. | Read More


By Vanita Pindolia, PharmD, Vice President of Ambulatory Clinical Pharmacy Programs at Henry Ford Health System & Health Alliance Plan, and Whitney Aultman, PharmD, an Ambulatory Care Pharmacy Resident at Beaumont Hospital

Cardiovascular (CV) disease is the leading cause of early death in diabetic patients, and multiple clinical trials have assessed new antidiabetic medication classes. | Read More

By David Costill

Troyen Brennan, MD, executive vice president and chief medical officer at CVS Health, discusses how CVS Health's prescription savings program offers discounts on certain medications directly to patients. | Read More

By Tom Morrow, MD, chief medical officer at Next IT and VIVIO Health, and a First Report Managed Care Editorial Advisory Board member.

Tom Morrow, MD, discusses the cost of PCSK9 Inhibitors and how they impacted patient response rates in a recent study.  | Read More
Elements of the patient-centered medical home (PCMH) model most strongly linked with clinical quality are care coordination, access, continuity, and communication, according to a recent study in JAMA Internal Medicine. | Read More